Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

SCAI.16: Robotic-assisted PCIs have similar outcomes to manual PCIs

A prospective analysis found that patients with significant comorbidities and complex coronary artery anatomy have similar outcomes if they undergo robotically assisted or manual PCI.

Carotid artery stenting and carotid endarterectomy lead to similar outcomes in Medicare patients

After adjusting for patient- and provider-level factors, Medicare patients had similar rates of death, stroke/transient ischemic attack, periporocedural MI and a composite of those outcomes if they underwent carotid artery stenting or carotid endarterectomy, according to a retrospective cohort study.

Video compares TAVR and surgery for intermediate-risk patients

A short video from the New England Journal of Medicine provides an overview of a study comparing transcatheter and surgical aortic valve replacement in intermediate-risk patients. 

FDA approves ICDs for atrial fibrillation

The FDA approved the Visia AF MRI SureScan and Visia AF single-chamber implantable cardioverter defibrillators (ICDs) on May 2 to treat patients with atrial fibrillation.

Subgroup analysis shows IN.PACT Admiral drug-coated balloon is effective in females and diabetics

Medtronic released results of a few studies involving its IN.PACT Admiral drug-coated balloon in patients with peripheral artery disease.

Bleeding rates following PCI vary depending on hospital, patient factors

A registry analysis of PCI procedures found patient factors accounted for 20 percent of the overall hospital-level variation in bleeding.

Atrial fibrillation may contribute to worse outcomes among patients undergoing TAVR

Patients undergoing transcatheter aortic valve replacement (TAVR) who had pre-existing or new-onset atrial fibrillation had higher rates of all-cause mortality, cardiac mortality and bleeding events compared with those who did not have atrial fibrillation, according to a registry analysis.

Strong TAVR sales help Edwards Lifesciences increase revenue in first quarter

Led by a 37 percent increase in its transcatheter heart valve sales, Edwards Lifesciences reported on April 26 that its revenue increased 18.1 percent and its earnings per share increased 17.9 percent during the first quarter of 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.